Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1135 | 1046 | 1159 | 1210 | 1703 | 2951 |
Fund Return | 13.52% | 4.64% | 15.94% | 6.57% | 11.24% | 11.43% |
Place in category | 268 | 583 | 187 | 145 | 76 | 61 |
% in Category | 27 | 62 | 22 | 26 | 18 | 17 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Danske Invest Japani Osake T | 643.99K | 7.48 | 9.08 | 8.49 | ||
Danske Invest Japani Osake K | 28.06M | 7.45 | 9.07 | 8.48 | ||
Danske Invest Kompassi 25 Acc | 1.45B | 4.46 | -0.68 | 2.85 | ||
Danske Invest Kompassi 25 Inc | 1.45B | 4.49 | -0.67 | 2.85 | ||
Danske Invest Kompassi 50 Acc | 926.36M | 7.03 | 1.13 | 4.40 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Danske Invest MediLife K | 89.69M | 13.52 | 6.56 | 11.42 | ||
Seligson Global Top 25 Pharmac B | 271.45M | 7.05 | 7.62 | 7.36 | ||
Seligson Co Global Top 25 Pharma A | 271.45M | 7.05 | 7.62 | 7.33 | ||
LahiTapiola Hyvinvointi A | 133.66M | 3.50 | -0.23 | 7.69 | ||
LahiTapiola Hyvinvointi B | 133.66M | 3.50 | -0.23 | 7.69 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 9.90 | 748.01 | -0.25% | |
Novo Nordisk ADR | US6701002056 | 7.72 | 105.06 | +2.37% | |
AbbVie | US00287Y1091 | 5.23 | 176.95 | +3.04% | |
AstraZeneca ADR | US0463531089 | 4.86 | 65.63 | +2.13% | |
Merck&Co | US58933Y1055 | 4.48 | 99.18 | -0.70% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review